These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23302914)

  • 1. Anthrax drug first antibacterial mAb to win approval.
    Fox JL
    Nat Biotechnol; 2013 Jan; 31(1):8. PubMed ID: 23302914
    [No Abstract]   [Full Text] [Related]  

  • 2. Fearful of Avastin's fate, Genentech asks for unusual hearing.
    Ratner M
    Nat Med; 2011 Mar; 17(3):233. PubMed ID: 21383702
    [No Abstract]   [Full Text] [Related]  

  • 3. Protecting against future shock--inhalational anthrax.
    Nabel GJ
    N Engl J Med; 2009 Jul; 361(2):191-3. PubMed ID: 19587345
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining 'standards' for biosimilar monoclonal antibodies.
    Prior S; Metcalfe C; Hufton SE; Wadhwa M; Schneider CK; Burns C
    Nat Biotechnol; 2021 Mar; 39(3):276-280. PubMed ID: 33664522
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract]   [Full Text] [Related]  

  • 7. Raxibacumab for anthrax.
    Med Lett Drugs Ther; 2013 Apr; 55(1413):27-8. PubMed ID: 23545582
    [No Abstract]   [Full Text] [Related]  

  • 8. Genentech and IDEC await approval of lymphoma Mab.
    Nat Biotechnol; 1997 Apr; 15(4):301. PubMed ID: 9094110
    [No Abstract]   [Full Text] [Related]  

  • 9. Commercial development considerations for biotechnology-derived therapeutics.
    Marafino BJ; Pugsley MK
    Cardiovasc Toxicol; 2003; 3(1):5-12. PubMed ID: 12668886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 12. Spinning the wheel on ImClone.
    Varchaver N
    Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
    [No Abstract]   [Full Text] [Related]  

  • 13. Can cancer clinical trials be fixed?
    Allison M
    Nat Biotechnol; 2011 Jan; 29(1):13-5. PubMed ID: 21221090
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in regulations for approval of therapeutics.
    Reichert JM
    MAbs; 2010; 2(4):359-60. PubMed ID: 25225706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HHS: POUFA reauthorization good for Americans.
    FDA Consum; 2002; 36(5):5. PubMed ID: 12412536
    [No Abstract]   [Full Text] [Related]  

  • 16. Raxibacumab.
    Mazumdar S
    MAbs; 2009; 1(6):531-8. PubMed ID: 20068396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs with breakthrough status charm investors.
    Senior M
    Nat Biotechnol; 2013 Nov; 31(11):945-7. PubMed ID: 24213748
    [No Abstract]   [Full Text] [Related]  

  • 19. The Anthrax Vaccine Program: an analysis of the CDC's recommendations for vaccine use.
    Nass M
    Am J Public Health; 2002 May; 92(5):715-21. PubMed ID: 11988433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.